Comparison of Mycoplasma hyopneumoniae and porcine circovirus 2 commercial vaccines efficacy when applied separate or combined under experimental conditions

Table 3 Total number (percentage) and mean (minimum and maximum) macroscopic score of animals showing CVPC or CVPC+BIP per treatment group

Treatment	Animals showing CVPC		Animals showing CVPC + BIP
Treatment	Proportion of animals with lesions (%)	Mean CVPC Score (Min-Max)	Proportion of animals with lesions (%)	Mean CVPC Score (Min-Max)
NV-NC	0/3 (0)	0 ^a	0/3^a (0)	0 ^A
NV-C Mhyo	12/15 (80)	6.23^b (0.12–38.63)	10/15^b (66.6)	7.26^B (38.63–0.60)
VS-C Mhyo	7/14 (50)	0.62^a (0.18–1.20)	2/14^a (14.3)	0.75^A (1.20–0.30)
VC-C Mhyo	6/14 (43)	0.84^a (0.12–2.48)	1/14^a (7.2)	0.53^A

Different low case letters in superscript within a column mean p < 0.05; different capital letters in superscript within a column mean p < 0.1

ISSN: 2055-5660